Keros Therapeutics Inc (KROS)

Working Capital Ratio

88.57%

Quarterly · Period ending:

KROS logo

KROS Working Capital Ratio

Latest reported88.57%
KROS Quarterly Working Capital Ratio (40.54% → 88.57%)
High-resolution chart · PNG

KROS working capital ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Working Capital Ratio — Quarterly
Period endingWorking Capital Ratio
88.5709%
88.9626%
87.2786%
93.596%
92.1993%
91.7876%
91.1602%
90.2926%
90.4284%
91.476%
87.2698%
88.1951%
89.3089%
90.2007%
87.7564%
92.7935%
91.2835%
93.3785%
93.866%
93.5194%
96.0671%
95.8491%
96.6965%
93.7394%
93.2098%
78.6969%
40.5386%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.